Abeona Therapeutics Inc.'s (NASDAQ:ABEO) stock traded higher on Wednesday.
The Food and Drug Administration (FDA) on Tuesday approved Abeona’s Zevaskyn (prademagene zamikeracel) gene-modified cellular sheets, also known as pz-cel, as the first and only autologous cell-based gene therapy…